The global dyslipidemia treatment market is experiencing significant development in the coming years. This situation can be attributed to a rising prevalence of cardiovascular diseases, coupled with aging populations. The market is dominated by key players who are always seeking new solutions novel treatment options. Key segments within the dyslip